Back to results
Bibliographic record · Consultation and access
Artículo de revista

Development of Reversible Posterior Leukoencephalopathy Syndrome after Cyclophosphamide Treatment in a Patient with Lupus Nephritis

Serkan YILDIZ et al · Turkish Society of Nephrology · 2019

Open-access full text
Quick overview. Review the resource’s basic details, then access the content using the main button. This page shows only the information needed to identify, cite, and open the work.
Serial publication

"ONE HUNDRED AND THIRTY-FIVE HOURS UNDER THE RUIN : A CASE WITH TRAUMATIC RHABDOMYOLYSIS IN GÖLCÜK EARTHQUAKE"

This serial publication contains 1.344 related contents.

Resource access

Open the content from the main option or choose another available source.

DOAJ DOAJ Articles
Entrar por DOAJ
Main access

Open-access full text

Texto completo identificado como acceso abierto.
Open text
Otras opciones de acceso Elegí el proveedor disponible para esta ficha.
DOAJ CSV Export DOAJ - Open Access Journals
Acceder por DOAJ CSV Export
DOAJ OAI-PMH DOAJ Articles
Acceder por DOAJ OAI-PMH

Other available options

When the resource is available on more than one platform, you can choose where to open it.

DOAJ CSV Export DOAJ - Open Access Journals Access available
Open
DOAJ OAI-PMH DOAJ Articles Access available
Open

Summary

Descripción general del contenido del recurso.

Renal involvement in systemic lupus erythematosus is a frequent and serious complication that significantly increases morbidity and mortality. Despite all studies and usage of new drugs, treatment of lupus nephritis continues to be a problem. Diffuse proliferative lupus nephritis has a poor prognosis and aggressive treatment must be undertaken. Cyclophosphamide is commonly used in treatment despite its side effects. Reversible posterior leucoencephalopathy syndrome is a clinico-radiological syndrome manifested by blood pressure elevation, headache, visual disturbances, confusion, seizures and sometimes focal neurological signs that can develop due to usage of cytotoxic drugs. We present a case of lupus nephritis in which reversible posterior leucoencephalopathy syndrome developed after intravenous cyclophosphamide administration and recovered spontaneously by symptomatic treatment in this article.

How to cite

Elegí el formato que necesitás y copiá la referencia al portapapeles.

APA 7

al, S. Y. E. (2019). Development of Reversible Posterior Leukoencephalopathy Syndrome after Cyclophosphamide Treatment in a Patient with Lupus Nephritis. https://turkjnephrol.org/index.php/pub/article/view/735

MLA

al, Serkan YILDIZ et. "Development of Reversible Posterior Leukoencephalopathy Syndrome after Cyclophosphamide Treatment in a Patient with Lupus Nephritis." 2019. https://turkjnephrol.org/index.php/pub/article/view/735.

Chicago

al, Serkan YILDIZ et. 2019. "Development of Reversible Posterior Leukoencephalopathy Syndrome after Cyclophosphamide Treatment in a Patient with Lupus Nephritis.". https://turkjnephrol.org/index.php/pub/article/view/735.

Harvard

al, S. Y. E. 2019, Development of Reversible Posterior Leukoencephalopathy Syndrome after Cyclophosphamide Treatment in a Patient with Lupus Nephritis, Turkish Society of Nephrology, available at: https://turkjnephrol.org/index.php/pub/article/view/735 [Accessed 7 Aug. 2026].

Share and print

Save the record, copy its permanent link, or print it as a PDF.

Export reference

You can export the record in common formats for use in a reference manager.

Resource details

Bibliographic information to help confirm that this is the correct material.

Title
Development of Reversible Posterior Leukoencephalopathy Syndrome after Cyclophosphamide Treatment in a Patient with Lupus Nephritis
Author / contributors
Serkan YILDIZ et al
Publisher
Turkish Society of Nephrology
Publication year
2019
ISSN
2667-4440
ISSN
2667-4440
Language
English

Subjects

Explore related resources through these subjects.

Copied